Normal Tension Glaucoma: Diagnosis and Treatment Explained
Glaucoma is often associated with raised intraocular pressure (IOP), but a significant subset of patients develop optic nerve damage despite having pressures within the statistically “normal” range. This condition, known as normal tension glaucoma (NTG), presents unique diagnostic and therapeutic challenges and is particularly relevant in modern ophthalmic practice.
What is Normal Tension Glaucoma?
Normal tension glaucoma is a form of glaucoma in which characteristic optic nerve damage and visual field loss occur despite IOP consistently measuring within the normal range (typically ≤21 mmHg). It is often considered a subtype of primary open-angle glaucoma, sharing similar structural and functional features but differing in its pressure profile.
NTG is more prevalent in certain populations, particularly in East Asia, and tends to present later in life. It is also more common in individuals with vascular risk factors, suggesting a multifactorial pathogenesis beyond pressure alone.
Pathophysiology: Beyond Pressure
The exact cause of NTG remains incompletely understood, but several mechanisms are implicated:
• Vascular dysregulation: Impaired blood flow to the optic nerve head may lead to chronic ischemia. Conditions like migraine, Raynaud’s phenomenon, and nocturnal hypotension are commonly associated.
• Increased optic nerve susceptibility: Some optic nerves may be structurally more vulnerable to even normal IOP levels.
• Low cerebrospinal fluid (CSF) pressure: This may increase the translaminar pressure gradient, placing stress on the optic nerve.
• Oxidative stress and neurodegeneration: Mechanisms similar to central nervous system degenerative diseases may play a role.
Understanding these factors is crucial, as they influence both diagnosis and management.
Diagnosis of Normal Tension Glaucoma
Diagnosing NTG is essentially a diagnosis of exclusion and requires careful, longitudinal assessment.
1. Intraocular Pressure Measurement
By definition, IOP remains within the normal range. However, single measurements are insufficient. Diurnal variation should be assessed, as some patients may have undetected spikes.
2. Optic Nerve Assessment
Structural changes are central to diagnosis:
• Increased cup-to-disc ratio
• Focal neuroretinal rim thinning or notching
• Optic disc hemorrhages (more common in NTG than high-pressure glaucoma)
Imaging with optical coherence tomography (OCT) helps quantify retinal nerve fiber layer (RNFL) thinning.
3. Visual Field Testing
Standard automated perimetry reveals characteristic defects:
• Paracentral scotomas
• Nasal steps
• Defects closer to fixation compared to high-pressure glaucoma
Progression over time is a key diagnostic feature.
4. Excluding Secondary Causes
Other causes of optic neuropathy must be ruled out, including:
• Compressive lesions (e.g. tumors)
• Ischemic optic neuropathy
• Inflammatory or demyelinating disease
Neuroimaging may be required in atypical cases, especially if visual field loss is disproportionate or asymmetric.
5. Risk Factor Assessment
A thorough history is essential. Look for:
• Systemic hypotension (especially nocturnal dips)
• Cardiovascular disease
• Migraine or vasospastic conditions
• Sleep apnea
These factors often guide management.
When to Treat?
Not all patients with NTG require immediate treatment. The decision depends on:
• Evidence of progression (structural or functional)
• Severity at presentation
• Patient age and life expectancy
• Risk factors for further damage
The Collaborative Normal-Tension Glaucoma Study demonstrated that lowering IOP by around 30% reduces the risk of progression, even when baseline pressure is normal.
Treatment Strategies
1. Lowering Intraocular Pressure
Despite “normal” IOP, reducing pressure remains the cornerstone of treatment.
Topical Medications
First-line therapy typically includes:
• Prostaglandin analogues (e.g. latanoprost)
• Beta-blockers
• Carbonic anhydrase inhibitors
• Alpha agonists
Prostaglandins are often preferred due to their potency and once-daily dosing.
Laser Therapy
Selective laser trabeculoplasty (SLT) can be effective in lowering IOP, even in NTG, and may reduce reliance on drops.
Surgery
In progressive cases, surgical intervention may be required:
• Trabeculectomy
• Glaucoma drainage devices
Surgery aims for lower target pressures than in typical glaucoma, often in the low teens or even single digits.
2. Addressing Vascular Factors
Given the importance of blood flow:
• Avoid excessive nocturnal hypotension (review antihypertensives)
• Manage cardiovascular risk factors
• Encourage hydration and healthy lifestyle habits
Some clinicians consider calcium channel blockers in selected patients, although evidence remains limited.
3. Neuroprotection
There is growing interest in therapies that directly protect retinal ganglion cells. While no agents are definitively proven, ongoing research explores:
• NMDA receptor antagonists
• Antioxidants
• Lifestyle interventions (exercise, diet)
4. Monitoring and Follow-Up
NTG requires close monitoring:
• Regular visual field testing (every 6–12 months)
• OCT imaging
• Optic disc photography
Progression can be subtle, and early detection is key to preserving vision.
Prognosis
The course of NTG is highly variable. Some patients remain stable for years without treatment, while others progress despite aggressive therapy. Compared to high-pressure glaucoma, NTG often:
• Progresses more slowly
• Causes earlier central visual field loss
• Requires lower target pressures
Disc hemorrhages are a particularly important marker of active disease and increased risk of progression.
Key Takeaways
• Normal tension glaucoma is a subtype of glaucoma characterized by optic nerve damage despite normal IOP.
• Diagnosis relies on structural and functional evidence, with exclusion of other optic neuropathies.
• Lowering IOP remains the only proven treatment, even in the normal range.
• Vascular factors and systemic health play a significant role and should be addressed.
• Careful, long-term monitoring is essential to detect progression early.
Normal tension glaucoma challenges the traditional pressure-centric view of glaucoma and highlights the complexity of optic nerve health. For clinicians, it demands a broader perspective—one that integrates ocular findings with systemic physiology to deliver truly individualized care.